8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Inorganic Biochemistry

• Publication date

  2014-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jinorgbio.2014.04.011PMID 25019963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease.

  2014cited by this paper
• Quantification of copper binding to amyloid precursor protein domain 2 and its Caenorhabditis elegans ortholog. Implications for biological function.

  2014cited by this paper
• A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease.

  2014cited by this paper
• Copper prevents amyloid-β1–42 from forming amyloid fibrils under near-physiological conditions in vitro

  2013cited by this paper
• Insights into antiamyloidogenic properties of the green tea extract (−)-epigallocatechin-3-gallate toward metal-associated amyloid-β species

  2013cited by this paper
• The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity.

  2013cited by this paper
• Clawing back: broadening the notion of metal chelators in medicine.

  2013cited by this paper
• Werner coordination chemistry and neurodegeneration.

  2013cited by this paper
• Hexafluoroisopropanol induces self‐assembly of β‐amyloid peptides into highly ordered nanostructures

  2012cited by this paper
• The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases

  2012cited by this paper
• Significant omissions of copper-amyloid research in ‘Metal Ions in Neurodegenerative Diseases’ special issue (CCR 256 (19,20) 2012)

  2012cited by this paper
• Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.

  2012cited by this paper
• Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders

  2012cited by this paper
• Misfolded proteins in Alzheimer's disease and type II diabetes.

  2012cited by this paper
• Therapeutic redistribution of metal ions to treat Alzheimer's disease.

  2012cited by this paper
• Reactivity of diphenylpropynone derivatives toward metal-associated amyloid-β species.

  2012cited by this paper
• Influence of susceptibility to hydrolysis and hydrophobicity of arylsemicarbazones on their anti-nociceptive and anti-inflammatory activities.

  2012cited by this paper
• Dual-function triazole-pyridine derivatives as inhibitors of metal-induced amyloid-β aggregation.

  2012cited by this paper
• Metals, Membranes, and Amyloid-β Oligomers: Key Pieces in the Alzheimer's Disease Puzzle?

  2012cited by this paper
• Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide.

  2012cited by this paper
• Metal ions, Alzheimer's disease and chelation therapy

  2011cited by this paper
• Copper(II) complexes of hybrid hydroxyquinoline-thiosemicarbazone ligands: GSK3β inhibition due to intracellular delivery of copper.

  2011cited by this paper
• The Alzheimer’s therapeutic PBT2 promotes amyloid‐β degradation and GSK3 phosphorylation via a metal chaperone activity

  2011cited by this paper
• Iron(II) binding to amyloid-β, the Alzheimer's peptide.

  2011cited by this paper
• N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy

  2011cited by this paper
• Binuclear zinc(II) complexes with the anti-inflammatory compounds salicylaldehyde semicarbazone and salicylaldehyde-4-chlorobenzoyl hydrazone (H2LASSBio-1064)

  2011cited by this paper
• Resolving controversies on the path to Alzheimer's therapeutics

  2011cited by this paper
• Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity

  2010cited by this paper
• PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses

  2010cited by this paper
• Alzheimer's disease: a general introduction and pathomechanism.

  2010cited by this paper
• PAN-811 Inhibits Oxidative Stress-Induced Cell Death of Human Alzheimer's Disease-Derived and Age-Matched Olfactory Neuroepithelial Cells Via Suppression of Intracellular Reactive Oxygen Species

  2009cited by this paper
• Gaussian 09W, revision A. 02

  2009cited by this paper
• Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy.

  2009cited by this paper
• Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation

  2009cited by this paper
• S-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury

  2009cited by this paper
• Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.

  2009cited by this paper
• Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.

  2008cited by this paper
• Neuroscience: The plaque plan

  2008cited by this paper
• A short history of SHELX.

  2008cited by this paper
• Drug Development Based on the Metals Hypothesis of Alzheimer's Disease

  2008cited by this paper
• Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.

  2008cited by this paper
• Metal based neurodegenerative diseases - From molecular mechanisms to therapeutic strategies

  2008cited by this paper
• Mercury CSD 2.0 – new features for the visualization and investigation of crystal structures

  2008cited by this paper
• Syntheses, characterization and crystal structures of mixed-ligand Cu(II), Ni(II) and Mn(II) complexes of N-(1-phenyl-3-methyl-4-propenylidene-5-pyrazolone)-salicylidene hydrazide containing ethanol or pyridine as a co-ligand

  2008cited by this paper
• Aβ Oligomers – a decade of discovery

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.

  2007cited by this paper
• Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases

  2007cited by this paper
• Potentiometric and spectrophotometric pKa determination of water-insoluble compounds: validation study in a new cosolvent system.

  2007cited by this paper
• Combating Alzheimer's disease with multifunctional molecules designed for metal passivation.

  2007cited by this paper
• Synthesis and characterization of new copper thiosemicarbazone complexes with an ONNS quadridentate system: cell growth inhibition, S-phase cell cycle arrest and proapoptotic activities on cisplatin-resistant neuroblastoma cells

  2007cited by this paper
• A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity*

  2006cited by this paper
• Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).

  2006cited by this paper
• Chelators at the Cancer Coalface: Desferrioxamine to Triapine and Beyond

  2006cited by this paper
• Virtual Computational Chemistry Laboratory – Design and Description

  2005cited by this paper
• 2-[(8-Hydroxyquinolinyl)methylene]hydrazinecarboxamide: expanding the coordination sphere of 8-hydroxyquinoline for coordination of rare-earth metal(III) ions.

  2005cited by this paper
• Cu(II) complexation by "non-coordinating" N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES buffer).

  2005cited by this paper
• Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes.

  2004cited by this paper
• Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides

  2004cited by this paper
• UV photoelectron spectroscopic study of substituent effects in quinoline derivatives.

  2004cited by this paper
• Neurodegenerative diseases and oxidative stress

  2004cited by this paper
• Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.

  2003cited by this paper
• Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

  2003cited by this paper
• An autocatalytic reaction as a model for the kinetics of the aggregation of β‐amyloid

  2003cited by this paper
• Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss

  2003cited by this paper
• The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes.

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity.

  2001cited by this paper
• Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

  2001cited by this paper
• Structural and spectroscopic characteristics of aroylhydrazones derived from nicotinic acid hydrazide

  2001cited by this paper
• New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity*

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• Antioxidant activity applying an improved ABTS radical cation decolorization assay.

  1999cited by this paper
• Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion*

  1999cited by this paper
• Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

  1999cited by this paper
• Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species

  1999cited by this paper
• WinGX suite for small-molecule single-crystal crystallography

  1999cited by this paper
• Determination of equilibrium constants from spectrophometric data obtained from solutions of known pH : The program pHab

  1999cited by this paper
• Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis*

  1998cited by this paper
• ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI)

  1997cited by this paper
• ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI) by J. Farrugia

  1997cited by this paper
• The Relationship of Intracellular Iron Chelation to the Inhibition and Regeneration of Human Ribonucleotide Reductase*

  1996cited by this paper
• Solvent effects on self-assembly of beta-amyloid peptide.

  1995cited by this paper
• Ab Initio Calculation of Vibrational Absorption and Circular Dichroism Spectra Using Density Functional Force Fields

  1994cited by this paper
• Rapid induction of Alzheimer A beta amyloid formation by zinc.

  1994cited by this paper
• Density-functional thermochemistry. III. The role of exact exchange

  1993cited by this paper
• Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators.

  1993cited by this paper
• Intramuscular desferrioxamine in patients with Alzheimer's disease.

  1991cited by this paper
• Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.

  1991cited by this paper
• Determination of the partition coefficient and acid dissociation constants of iodochlorhydroxyquin by an improved partition method.

  1984cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• A guidebook to mechanism in organic chemistry

  1970cited by this paper

• Zinc sequestering dual-functional molecules for bimodal targeting inhibition of Aβ42-aggregation.

  2026cites this paper
• Impact of copper(II) complexes on increase in lifespan and mean survival of gld-1 mutant strain JK1466 in Caenorhabditis elegans

  2026cites this paper
• The binding of kojic acid dimer and its Zn(II) and Cu(II) complexes at the beta-amyloid peptide: A DFT-based computational assessment.

  2025cites this paper
• Guanylhydrazone and semicarbazone derivatives as potential prototypes for the design of cholinesterase inhibitors against Alzheimer's disease: biological evaluation and molecular modeling studies.

  2025cites this paper
• Evaluation of a New Methylimidazole‐Containing Thiosemicarbazone as a Cu+/Cu2+‐Targeting Ligand in the Context of Alzheimer's Disease

  2025cites this paper
• Harnessing copper: Innovative approaches to combat neurodegenerative diseases and cancer (Review)

  2025cites this paper
• Photoactivatable Ru(ii) polypyridyl complexes as dual action modulators of amyloid-beta peptide aggregation and Cu redox cycling

  2025cites this paper
• Copper-Aβ and cytochrome c: a potential Janus in Alzheimer's disease.

  2025cites this paper
• Metal‐Responsive Up‐Regulation of Bifunctional Disulfides for Suppressing Protein Misfolding and Promoting Oxidative Folding

  2025cites this paper
• Structural studies and physicochemical properties of indium(III) complexes with 2-formyl-8-hydroxyquinoline-derived hydrazones

  2024cites this paper
• Thermodynamics, optical properties, and coordination of lanthanoids with hydroxyquinolate functionalised receptor

  2024cites this paper
• A Multipurpose Metallophore and Its Copper Complexes with Diverse Catalytic Antioxidant Properties to Deal with Metal and Oxidative Stress Disorders: A Combined Experimental, Theoretical, and In Vitro Study

  2024cites this paper
• The impact of chelating compounds on Cu2+, Fe2+/3+, and Zn2+ ions in Alzheimer's disease treatment.

  2024cites this paper
• Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules.

  2024cites this paper
• Bifunctional Copper Chelators Capable of Reducing Aβ Aggregation and Aβ-Induced Oxidative Stress

  2024cites this paper
• Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer’s Disease

  2023cites this paper
• Memantine-Derived Schiff Bases as Transdermal Prodrug Candidates

  2022cites this paper
• Tridentate N-Acylhydrazones as Moderate Ligands for the Potential Management of Cognitive Decline Associated With Metal-Enhanced Neuroaggregopathies

  2022cites this paper
• Insights of metal 8-hydroxylquinolinol complexes as the potential anticancer drugs.

  2022cites this paper
• Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

  2022cites this paper
• Simultaneous binding of heme and Cu with amyloid β peptides: active site and reactivities.

  2022cites this paper
• Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease

  2021cites this paper
• Bis (Diamines) Cu and Zn Complexes of Flurbiprofen as Potential Cholinesterase Inhibitors: In Vitro Studies and Docking Simulations

  2021cites this paper
• Synthesis, characterization and pharmacological evaluation of quinoline derivatives and their complexes with copper(ΙΙ) in in vitro cell models of Alzheimer's disease.

  2021cites this paper
• Electronic investigation of the effect of substituents on the SOD mimic activity of copper (II) complexes with 8-hydroxyquinoline-derived ligands.

  2021cites this paper
• Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru(ii) polypyridyl complexes†

  2021cites this paper
• Rational Design of a Cu Chelator That Mitigates Cu‐Induced ROS Production by Amyloid Beta

  2021cites this paper
• The Effects of Redox-Active Metal Ions and Amyloid-Degrading Enzymes on the Pathology of Alzheimer's Disease

  2021cites this paper
• Ruthenium(II)–arene complexes with chelating quinoline ligands as anti-amyloid agents

  2021cites this paper
• Metals and Metal-Nanoparticles in Human Pathologies: From Exposure to Therapy

  2021cites this paper
• Carbazole-based semicarbazones and hydrazones as multifunctional anti-Alzheimer agents

  2021cites this paper
• Retracted Article: A new Ho(III) dinuclear complex: treatment activity and cure values on mania by reducing the expression of the ErbB4 on the noradrenergic neurons

  2020cites this paper
• Carnoquinolines Target Copper Dyshomeostasis, Aberrant Protein-Protein Interactions, and Oxidative Stress.

  2020cites this paper
• Novel multifunctional iron chelators of the aroyl nicotinoyl hydrazone class that markedly enhance cellular NAD+/NADH ratios

  2020influential citation
• Synthesis, protonation constants and biological activity determination of amino acid–salicylaldehyde-derived Schiff bases

  2020cites this paper
• Evaluation of ct-DNA and HSA binding propensity of antibacterial drug chloroxine: Multi-spectroscopic analysis, atomic force microscopy and docking simulation.

  2020cites this paper
• Explication of human γD-crystallin interactions with its aggregation inhibitor Schiff base at molecular level

  2020cites this paper
• Thiosemicarbazone Derivatives as Inhibitors of Amyloid-β Aggregation: Effect of Metal Coordination.

  2020cites this paper
• X1INH, an improved next-generation affinity-optimized hydrazonic ligand, attenuates abnormal copper(i)/copper(ii)-α-Syn interactions and affects protein aggregation in a cellular model of synucleinopathy.

  2020cites this paper
• Computational Design of Copper Ligands with Controlled Metal Chelating, Pharmacokinetics, and Redox Properties for Alzheimer’s Disease

  2020cites this paper
• The essential elements of Alzheimer’s disease

  2020cites this paper
• Physicochemical characterization of antimony(III), copper(II) and silver(I) complexes with 4-nitroimidazole-derived hydrazones

  2020cites this paper
• Multifunctional compounds for the treatment of Alzheimer’s disease

  2020cites this paper
• The aroylhydrazone INHHQ prevents memory impairment induced by Alzheimer’s-linked amyloid-β oligomers in mice

  2020cites this paper
• Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes

  2019cites this paper
• Synthesis of two platinum(II) complexes with 2-methyl-8-quinolinol derivatives as ligands and study of their antitumor activities.

  2019cites this paper
• Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies.

  2019cites this paper
• High in vitro and in vivo antitumor activities of Ln(III) complexes with mixed 5,7-dichloro-2-methyl-8-quinolinol and 4,4'-dimethyl-2,2'-bipyridyl chelating ligands.

  2019cites this paper
• Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments

  2019cites this paper
• Complexes of lanthanides(iii) with mixed 2,2'-bipyridyl and 5,7-dibromo-8-quinolinoline chelating ligands as a new class of promising anti-cancer agents.

  2019cites this paper
• Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.

  2019cites this paper
• Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease

  2019cites this paper
• Investigation of the antitrypanosomal effects of 2-formyl-8-hydroxyquinoline-derived hydrazones and their antimony(iii) and bismuth(iii) complexes

  2019cites this paper
• Novel chelators based on adamantane-derived semicarbazones and hydrazones that target multiple hallmarks of Alzheimer's disease.

  2018cites this paper
• Multifactorial Hypothesis and Multi-Targets for Alzheimer’s Disease

  2018cites this paper
• Hydrogen bond assisted interaction of glutamine with chromium (III) complex of 8-hydroxyquinoline: Experimental and theoretical studies

  2018cites this paper
• A catalytic antioxidant for limiting amyloid-beta peptide aggregation and reactive oxygen species generation

  2018cites this paper
• A small bifunctional chelator that modulates Aβ42 aggregation

  2018cites this paper
• Aroylhydrazones constitute a promising class of ‘metal-protein attenuating compounds’ for the treatment of Alzheimer’s disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone

  2018cites this paper
• Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.

  2018cites this paper
• Synthesis and structural characterization of a 8-hydroxyquinoline derivative coordinated to Zn(II)

  2018cites this paper
• Synthesis and Cytoprotective Characterization of 8-Hydroxyquinoline Betti Products

  2018cites this paper
• Carnosine-LVFFARK-NH2 Conjugate: A Moderate Chelator but Potent Inhibitor of Cu2+-Mediated Amyloid β-Protein Aggregation.

  2018cites this paper
• RTHLVFFARK-NH2: A potent and selective modulator on Cu2+-mediated amyloid-β protein aggregation and cytotoxicity.

  2018cites this paper
• Design of nonapeptide LVFFARKHH: A bifunctional agent against Cu2+‐mediated amyloid β‐protein aggregation and cytotoxicity

  2018cites this paper
• Nouvelles preuves de concept pour la chélatothérapie contre la maladie d'Alzheimer : études spectroscopiques des interactions entre les ions cuivre et zinc

  2017cites this paper
• A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease.

  2017cites this paper
• Inhibition of copper-mediated aggregation of human γD-crystallin by Schiff bases

  2017cites this paper
• Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc01269a Click here for additional data file.

  2017cites this paper
• Modulation effect of acidulated human serum albumin on Cu2+-mediated amyloid β-protein aggregation and cytotoxicity under a mildly acidic condition.

  2017cites this paper
• Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules.

  2017cites this paper
• Synthesis, characterization, crystal structure and DNA, HSA-binding studies of four Schiff base complexes derived from salicylaldehyde and isopropylamine

  2017cites this paper
• Investigation on the physicochemical properties of trans-4-stilbenecarboxaldehyde-derived hydrazones and their copper(II) complexes

  2017cites this paper
• Synthesis and antitumor mechanism of a new iron(iii) complex with 5,7-dichloro-2-methyl-8-quinolinol as ligands.

  2017cites this paper
• Synthesis, crystal structure, cytotoxicity and action mechanism of a Rh(iii) complex with 8-hydroxy-2-methylquinoline as a ligand.

  2017cites this paper
• ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy

  2016cites this paper
• Recent progress in multifunctional metal chelators as potential drugs for Alzheimer's disease

  2016cites this paper
• Structural and spectroscopic investigation on a new potentially bioactive di-hydrazone containing thiophene heterocyclic rings

  2016cites this paper
• Ni(II) and Pd(II) complexes with new N,O donor thiophene appended Schiff base ligand: Synthesis, electrochemistry, X-ray structure and DFT calculation

  2016cites this paper
• Thermodynamic insight into solvent-effect on structures and antifungal activities of manganese(II) complexes with acylhydrazone

  2016cites this paper
• ASS 234 , As a New Multi-Target Directed Propargylamine for Alzheimer ’ s Disease Therapy

  2016cites this paper
• Stabilization of c-myc G-Quadruplex DNA, inhibition of telomerase activity, disruption of mitochondrial functions and tumor cell apoptosis by platinum(II) complex with 9-amino-oxoisoaporphine.

  2016cites this paper
• A 2-Substituted 8-Hydroxyquinoline Stimulates Neural Stem Cell Proliferation by Modulating ROS Signalling

  2016cites this paper
• Multifunctional quinoline-triazole derivatives as potential modulators of amyloid-β peptide aggregation.

  2016cites this paper
• Possible role of metal ionophore against zinc induced cognitive dysfunction in d-galactose senescent mice

  2016cites this paper
• Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease

  2016cites this paper
• Frontiers in Clinical Drug Research - Alzheimer Disorders

  2015cites this paper
• Studies on antitumor mechanism of two planar platinum(II) complexes with 8-hydroxyquinoline: synthesis, characterization, cytotoxicity, cell cycle and apoptosis.

  2015cites this paper
• Disruption of zinc and copper interactions with Aβ(1-40) by a non-toxic, isoniazid-derived, hydrazone: a novel biometal homeostasis restoring agent in Alzheimer's disease therapy?

  2015cites this paper
• Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease.

  2015cites this paper
• Template synthesis of square-planar Ni(II) complexes with new thiophene appended Schiff base ligands: Characterization, X-ray structure and DFT calculation

  2015cites this paper